Dana-Farber Cancer Institute

New research is outlining the long-term efficacy of a novel type of cancer vaccine. The research followed eight skin cancer patients and found the experimental treatment offers durable and persistent immune responses to cancer cells up to four years later.

CAR T cell immunotherapy is a promising cancer treatment that supercharges natural tumor-hunting cells, but it can backfire with potentially deadly results. Now, scientists have engineered off switches for these immune cells.

Preliminary results from a small human trial testing a novel cancer drug revealed over half the cohort had their tumors stop growing completely. The drug, called berzosertib, is now moving to larger clinical trials.

Scientists at the Dana-Farber Cancer Institute have published a study describing a new type of blood test that can detect more than 20 types of cancer with a high degree of accuracy. Not only that, it can even trace them back to their source.

Scientists at the Dana-Farber Cancer Institute have developed a new approach to treating rheumatoid arthritis.

Researchers have discovered that a small molecule compound called JQ1 can produce reversible birth control in mice, thereby showing promise as a lead compound for the development of a reversible male contraceptive.

Researchers have confirmed the existence of a third type of fat cell, in addition to white and brown, that could be targeted in the fight against obesity.